Bluestein Ventures
VC Fund
Chicago, United States
Bluestein Ventures is a VC fund in Chicago focused on Food and Beverage and E-Commerce. Founded in 2009, Bluestein is a family-based venture capital fund that invests in the future of food. The firm is looking for game-changing ventures across the food industry that redefine how consumers achieve their health and wellness. The firm spans the entire value chain both B2C and B2B with a focus on four areas: high-growth consumer brands,proprietary food tech, next-gen commerce, and value-add digital technology. The firm is laser-focused on preeminent and defensible brands, services, technologies, and platforms that have the potential to transform the industry.
- Total investments:
- 39
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Bluestein Ventures invests in
Stages Bluestein Ventures invests in
Countries Bluestein Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Seed
- $1.4M–$5.3M
- Series A
- $4M–$25M
Investment Focus
Industry
- Food and Beverage 15 (38%)
- E-Commerce 6 (15%)
- Health Care 6 (15%)
- Biotechnology 5 (13%)
- Food Processing 5 (13%)
Stage
- Seed 19 (49%)
- Series A 6 (15%)
- Funding Round 5 (13%)
- Pre-Seed 3 (8%)
- Series B 2 (5%)
Country
- United States 31 (79%)
- Canada 1 (3%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Andrew Bluestein
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
Andrew Bluestein
Managing Partner
|
Managing Partner | Total investments: 4 | Find email | |
Ashley Hartman
Managing Partner
|
Managing Partner | Total investments: 1 | Find email | |
|
Cooper Clawson
Analyst
|
Analyst | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
AuX Labs
|
AuX Labs is a food technology company that uses precision fermentation methods to manufacture real dairy proteins. | $4M / Venture - Series Unknown / Apr 21, 2026 | |
Mezcla
|
Mezcla produces plant-based protein bars to provide snack alternatives. Its first product, the Puff-Crispy, replaces the traditional slab-style protein bar with an innovative, crunchy texture developed from puffed pea protein. The company's products use soy, dairy, and gluten-free ingredients to produce protein bars in various flavors such asvanilla, cocoa peanut butter, and hot chocolate to let customers enjoy a delicious and convenient snack that is also packed with protein and nutrients. | $9.5M / Series B / Mar 02, 2026 | |
ALTR
|
ALTR is a beverage company that offers technology and non-destructive process for reducing alcohol or drinks with less alcohol. | $5M / Seed / Jul 07, 2025 | |
Lembas
|
Lembas is a foodtech startup that has developed "GLP-1 Edge," a patent-pending peptide ingredient designed to naturally boost the GLP-1 hormone, which helps regulate appetite and metabolism for weight management. Using AI-driven discovery and licensed technology from Tel Aviv University, Lembas offers this peptide powder as abusiness-to-business ingredient for food and supplement brands, providing a science-backed, non-pharmaceutical alternative to weight loss drugs with no reported side effects | $3.6M / Pre-Seed / Jun 10, 2025 | |
Aerflo
|
Aerflo a transportable method of carbonating sparkling water. | $10M / Venture - Series Unknown / Aug 28, 2024 | |
|
AuX Labs
|
AuX Labs is a food technology company that uses precision fermentation methods to manufacture real dairy proteins. | $3M / Seed / Mar 20, 2024 | |
Jellatech
|
Jellatech is a B2B biotech business based in Raleigh, NC, and with R&D in Wageningen, Netherlands. Jellatech is producing high-quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs, and scientists, Jellatech is eliminating the dependency on animals, to make better ingredient products -starting with collagen and gelatin. | $3.5M / Seed / Aug 22, 2023 | |
BiomeSense
|
BiomeSense is developing the first technology platform for continuous, at-home monitoring of the human gut microbiome, transforming the ability to understand & utilize the microbiome for precision medicine. The enabling technology is the GutLab, the first “smart bathroom” system for at-home microbiome monitoring, which is combined with theMetaBiome time-series analytics platform into a single end-to-end solution. The platform allows scientists, patients, and consumers the unprecedented ability to tie microbiome changes directly to clinical outcomes in real time, revolutionizing the ability to leverage the microbiome for better health. | $3M / Seed / Feb 05, 2023 | |
People Science
|
People Science is a tech-led R&D platform for alternative medicine. | $5.3M / Seed / Jan 26, 2023 | |
Free From Market
|
Free From Market provides inclusive access to personalized, nutritious groceries and educational resources for those living with chronic health conditions. | $2.1M / Seed / Jan 26, 2023 | |
| See all 39 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Bluestein Ventures invest in?
Bluestein Ventures invests primarily in Food and Beverage, E-Commerce and Health Care startups, most often at Seed and Series A stage. Most of the 39 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Bluestein Ventures's check size?
Bluestein Ventures typically joins rounds of $1.4M–$5.3M at Seed and $4M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Bluestein Ventures participates in.
How do I contact Bluestein Ventures?
Public channels for Bluestein Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bluestein Ventures?
The team at Bluestein Ventures includes Andrew Bluestein (Managing Partner), Andrew Bluestein (Managing Partner) and Ashley Hartman (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
